MedTrace Logo

Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)

NCT00168090 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-02-11

No results posted yet for this study

Summary

The purpose of this study is to test the safety and effectiveness of Humate-P® to prevent bleeding in patients with von Willebrand Disease who are undergoing surgery.

Conditions

  • Von Willebrand Disease
  • Blood Coagulation Disorders
  • Blood Platelet Disorders
  • Hematologic Disease

Interventions

DRUG

Blood coagulation Factor VIII and vWF, human

Sponsors & Collaborators

  • CSL Behring

    lead INDUSTRY

Principal Investigators

  • Marylin J. Manco-Johnson, M.D. · Mountain States Regional Hemophilia Center, Aurora, Columbia, U.S.

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-10-31
Completion
2006-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00168090 on ClinicalTrials.gov